Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06840899 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later May 2027 → May 2028
See other at-risk trials from University of Wisconsin, Madison

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from May 2027 to May 2028
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 1 of 3 entries
  2. Re-verified, no change to tracked fieldsv15
  3. Start date changed from estimate of Feb 2026 to Feb 13, 2026v14
  4. Primary and study completion dates: Apr 2027 to May 2027
    • Start date: Jan 2026 to Feb 2026
    v13
  5. Start date: Dec 2025 to Jan 2026v12
Show 10 earlier versionsHide 10 earlier versions
  1. Primary and study completion dates: Mar 2027 to Apr 2027
    • Start date: Nov 2025 to Dec 2025
    v11
  2. Start date: Oct 2025 to Nov 2025v10
  3. Primary and study completion dates: Feb 2027 to Mar 2027
    • Start date: Sep 2025 to Oct 2025
    v9
  4. Start date: Aug 2025 to Sep 2025v8
  5. Primary and study completion dates: Jan 2027 to Feb 2027
    • Start date: Jul 2025 to Aug 2025
    v7
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jun 2025 to Jul 2025
    • Site details revised
    v6
  7. Start date: May 2025 to Jun 2025v5
  8. Start date: Apr 2025 to May 2025v4
  9. Start date: Mar 2025 to Apr 2025v3
  10. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days
Trial Details
NCT Number NCT06840899
Lead Sponsor University of Wisconsin, Madison
Conditions
(from sponsor)		 Supra-sacral Spinal Cord Injury, Spinal Cord Injury, Urinary Incontinence
Related terms Spinal Cord Injuries, Urinary Incontinence
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov